Document Detail

Observational study of mortality risk stratification by ischemic presentation in patients with acute type A aortic dissection: the Penn classification.
MedLine Citation:
PMID:  19065126     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Acute type A aortic dissection is a surgical emergency, with an operative mortality as high as 25%. Ischemia is a known predictor of mortality. We tested the efficacy of a classification system--the Penn classification, which is based on ischemic pattern at clinical presentation--to stratify operative mortality risk and identify high-risk groups of patients for further intervention and study. METHODS: In this prospective observational study, patients underwent a standard aortic dissection repair protocol at the University of Pennsylvania, Philadelphia, PA, from 1993 to 2004. Patients were classified as having no ischemia, branch vessel malperfusion with localized organ ischemia, generalized ischemia with circulatory collapse, with or without cardiac involvement, or a combination of localized and generalized ischemia. RESULTS: The cohort comprised 221 patients. The mean age was 61.6 (+/- 14.8) years and 66.5% were male. At presentation 57.9% of patients had no ischemia, 17.6% had localized ischemia, 15.4% had generalized ischemia, and 9.0% had both localized and generalized ischemia. Overall, 28 (12.7%) patients died during the perioperative period. All-cause mortality differed significantly between groups (no ischemia 3.1%, localized ischemia 25.6%, generalized ischemia 17.6%, combined ischemia 40.0%), yielding an overall 8.3-fold difference for no compared with any ischemia (3.1% versus 25.8%, P = 0.0001). Ischemic presentations together accounted for 85.7% of all deaths. CONCLUSION: The Penn classification of acute type A aortic dissection enabled stratification of patients by operative mortality risk. The system requires further validation, but might facilitate new ways to analyze mortality data for this disorder.
John G T Augoustides; Arnar Geirsson; Wilson Y Szeto; Elizabeth K Walsh; Brittany Cornelius; Alberto Pochettino; Joseph E Bavaria
Related Documents :
7729326 - Daily life cardiac ischaemia. should it be treated?
21103406 - Cardiac injury in patients with copd presenting with dyspnea: a pilot study.
9385506 - Rationale for the use of calcium antagonists in the treatment of silent myocardial isch...
9420696 - Investigation of myocardial metabolism for the study of the pathophysiology of cardiac ...
6502936 - Cardiac dimensions and motion shortly after mitral valve surgery.
22192666 - Risk stratification in brugada syndrome results of the prelude (programmed electrical s...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-12-09
Journal Detail:
Title:  Nature clinical practice. Cardiovascular medicine     Volume:  6     ISSN:  1743-4300     ISO Abbreviation:  -     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-28     Completed Date:  2009-03-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101226507     Medline TA:  Nat Clin Pract Cardiovasc Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  140-6     Citation Subset:  IM    
Department of Anesthesiology and Critical Care, Cardiothoracic and Vascular Section, Hospital of the University of Pennsylvania, Philadelphia, PA 19104-4283, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Aneurysm, Dissecting / complications,  mortality*,  surgery
Aortic Aneurysm / complications,  mortality*,  surgery
Health Status Indicators*
Middle Aged
Myocardial Ischemia / etiology,  mortality*
Pennsylvania / epidemiology
Predictive Value of Tests
Prospective Studies
Reproducibility of Results
Risk Assessment
Treatment Outcome
Vascular Surgical Procedures / mortality*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Obstructive sleep apnea and risk of stroke: time for a trial.
Next Document:  How effective is endoscopic therapy in the treatment of patients with early esophageal cancer?